Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Depressive disorder | D003866 | EFO_1002014 | F32.A | 3 | 1 | — | — | — | 4 |
Depression | D003863 | — | F33.9 | 1 | 1 | — | — | — | 2 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | 1 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 2 | — | — | — | — | 2 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | GSK163090 |
INN | — |
Description | Gsk163090 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1 |
PDB | — |
CAS-ID | 1297538-32-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1631540 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |